Smoking Cessation for Smokers With Sleep Problems



Status:Completed
Conditions:Insomnia Sleep Studies, Smoking Cessation, Tobacco Consumers
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 75
Updated:12/23/2017
Start Date:December 2010
End Date:March 2012

Use our guide to learn which trials are right for you!

This is a pilot research study examining two types of behavioral counseling along with the
nicotine patch for smoking cessation. The study is designed to find out whether one of these
counseling interventions is more effective for smoking cessation among individuals with sleep
problems. The study has three parts: 1) an intake session; 2) a 10-week treatment phase, and
3) a 1-month follow-up.

This is a developmental study to: 1) create and test an integrated cognitive-behavioral
smoking cessation and insomnia intervention with 30 smokers who report current insomnia.
Participants are randomized to 1 of 2 counseling conditions. The cognitive-behavioral
intervention provides standard care smoking counseling along with counseling to address
insomnia. The smoking counseling intervention provides standard care smoking counseling
adapted from the American Lung Association Freedom from Smoking program. Efficacy data from
this trial will be used to determine effect size estimates for biologically confirmed
self-reported point prevalence smoking abstinence at the end of treatment and 1 month after
completing treatment. Changes in sleep efficiency and self-control to resist smoking urges
will also be examined. If the effect size estimates are sufficiently large and medically
important to pursue a definitive trial, these data will be used to propose a full scale large
study.

Inclusion Criteria:

- Between the ages of 18 and 75.

- Smoking 10 or more cigarettes per day for at least 1 year.

- An expired air breath carbon monoxide level > 10 ppm.

- Motivated to stop smoking.

- Understand English.

- Meet DSM-IV criteria for insomnia.

- Report sleep latency or waking after sleep onset >30 minutes on ≥6 occasions within
past month.

Exclusion Criteria:

- History of allergic reactions to adhesives.

- Unstable psychiatric/medical conditions such as current suicidal or homicidal
ideation, acute psychosis, dementia.

- Have a current diagnosis of DSM-IV alcohol or drug dependence other than nicotine.

- Use of tobacco products other than cigarettes or use of marijuana.

- Intention to use nicotine replacement therapy, varenicline, or bupropion during study
participation.

- Females of childbearing potential who are pregnant, nursing, or not practicing
effective contraception (oral, injectable, or implantable contraceptives, intrauterine
device, or barrier method with spermicide).

- New onset of psychiatric disorders or new psychotropic medications within the past 3
months.

- Inability to read/understand English.

- History of sleep apnea based on responses to Berlin Questionnaire.

- History of restless leg syndrome.

- Current night or rotating shift work.

- Proposed travel across 2 or more time zones during study participation.

- Medical/psychiatric conditions contraindicated for sleep restriction (i.e., seizure
disorders, severe excessive daytime sleepiness - Epworth Scale >18, and bipolar
disorder).
We found this trial at
1
site
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials